Page last updated: 2024-10-30

ketotifen and Cruveilhier-Baumgarten Syndrome

ketotifen has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sánchez-Patán, F2
Aller, MA2
Cuellar, C2
Rodero, M2
Corcuera, MT1
Nava, MP1
Gómez, F1
Blanco, MD1
Guerrero, S1
Anchuelo, R2
Muñiz, E1
Alonso, MJ1
Teijón, JM1
Arias, J2
Vara, E1
Garcia, C1
Saavedra, Y1
Vergara, P1

Other Studies

2 other studies available for ketotifen and Cruveilhier-Baumgarten Syndrome

ArticleYear
Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2008, Volume: 60, Issue:4-5

    Topics: Animals; Anti-Allergic Agents; Enzyme-Linked Immunosorbent Assay; Hypertension, Portal; Inflammation

2008
Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2008, Volume: 7, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Cell Movement; Chymases; Disease Models, Animal; Eicosanoids; Hyp

2008